There were 1,423 press releases posted in the last 24 hours and 438,496 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
C4 Therapeutics to Present New Preclinical Data on Highly Selective Orally Bioavailable BiDAC™ Degraders at the American Association for Cancer Research Annual Meeting 2024

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image